Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × mCRC × Clear all

Phase

Status

Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 108 Breast Neoplasms 78 Colorectal Neoplasms 47 Carcinoma, Hepatocellular 43 Stomach Neoplasms 41 Lung Neoplasms 39 Prostatic Neoplasms 38 Squamous Cell Carcinoma of Head and Neck 37 Triple Negative Breast Neoplasms 35 Small Cell Lung Carcinoma 34 Rectal Neoplasms 31 Uterine Cervical Neoplasms 27 Recurrence 25 Pancreatic Neoplasms 25 Neoplasms 24 Neoplasm Metastasis 23 Leukemia, Myeloid, Acute 23 Esophageal Squamous Cell Carcinoma 23 Ovarian Neoplasms 21 Brain Neoplasms 20 Nasopharyngeal Carcinoma 18 Multiple Myeloma 18 Esophageal Neoplasms 17 Glioblastoma 16 Endometrial Neoplasms 15 Colonic Neoplasms 15 Carcinoma, Renal Cell 15 Biliary Tract Neoplasms 15 Lymphoma, Large B-Cell, Diffuse 14 Head and Neck Neoplasms 14

Interventions

trifluridine tipiracil drug combination 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07116577 2025-08-11

Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC

Jinan Central Hospital

Phase 2 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡